Article
Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages.
Lung cancer (Amsterdam, Netherlands) - 1 Jul 2013
Sumiyoshi Shinji, Yoshizawa Akihiko, Sonobe Makoto, Kobayashi Masashi, Fujimoto Masakazu, Tsuruyama Tatsuaki, Date Hiroshi, Haga Hironori
Abstract excerpt
Pulmonary adenocarcinoma with a micropapillary component (PA-MPC) is known to exhibit biologically aggressive behavior. The aim of this study was to evaluate the clinicopathological characteristics of early-stage PA-MPC and to investigate the correlation between PA-MPC and epidermal growth factor receptor (EGFR) or KRAS mutation status. We reviewed 440 PA patients who underwent resection. We defined PA-MPC as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.